Indonesia

in page functions
Total population (2012)244,769,110
Birth cohort (2012)4,289,805
Surviving Infants (surviving to 1 year per year, 2012)4,181,633
Infant mortality rate (deaths < 1 year per 1000 births, 2011)24.80/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)31.80/1000
Gross Nation Income (per capita US$, 2011)2,940
Co-financing status (2012)Graduating
No. of districts/territories (2011)497

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Indonesia

Type of support

Approvals

2001-2016 (US$)
(31 Mar 2013)

Commitments

2001-2016 (US$)
(31 Mar 2013)

Disbursements

2001-2012 (US$)
(31 Mar 2013)

% Disbursed

(31 Mar 2013)
20022003200420052006200720082011201220132014
Civil Society Organisation support (CSO)$3,900,500$3,900,500$4,000,500103%
Health System Strengthening (HSS)$11,684,000$24,827,500$11,684,000100%
HepB mono (NVS)$17,511,000$17,511,000$17,511,000100%
Immunisation Services Support (ISS)$12,636,000$12,636,000$12,636,000100%
Injection Safety Support (INS)$9,856,844$9,856,844$9,856,844100%
Penta (NVS)$10,024,000$23,970,000
Vaccine Introduction Grant$3,891,000$3,891,000$100,0003%
Total$69,503,344$96,592,844$55,788,344

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Indonesia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence
63%

*
DTP3 - Official country estimates (2011)83%
M:F sex ratio at birth (2012)1.05
Household survey: DTP3 coverage for male (2010)73.10%
Household survey: DTP3 coverage for female (2010)70.90%
Household survey: Last DTP3 survey (2010)72%
% districts achieving > 80% DTP3 coverage (2011)80%
% districts achieving < 50% DTP3 coverage (2011)4%
MCV WHO/UNICEF estimates (2011)89%
Polio WHO/UNICEF estimates (2011)70%

Breakdown of support

Non-vaccine supportVaccine support
69% 31%
$38,277,344 $17,511,000

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Indonesia

18 April 2013

Pentavalent infographic preview

Indian manufacturer cuts price of childhood vaccine by 30 percent

The cost of immunising millions of the world’s most vulnerable children against five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine. This new, more cost-effective price provides the opportunity for the GAVI Alliance to pay up to US$ 150 million less over the next four years compared with using lowest cost alternative suppliers.

25 March 2013

The Lancet

Global health leaders call for strong post-2015 focus

Seven of the world’s leading health and development agencies call for the High Level Panel of the post-2015 development agenda to ensure that health remains central to advance global prosperity in the post-2015 era.

10 January 2013

mopan

GAVI recognised for effectiveness and focus on results

In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.

close icon

modal window here